Journal of Ovarian Research

Article	Citations
Ovarian reserve in women with cystic fibrosis: is this a cause of sub-fertility?	103
CDCA5 promoted cell invasion and migration by activating TGF-β1 pathway in human ovarian cancer cells	92
The mechanisms of MicroRNA 21 in premature ovarian insufficiency mice with mesenchymal stem cells transplantation	47
Dehydroepiandrosterone supplementation and the impact of follicular fluid metabolome and cytokinome profiles in poor ovarian responders	47
Nicotinamide riboside supplementation ameliorates ovarian dysfunction in a PCOS mouse model	42
Artificial oocyte activation may improve embryo quality in older patients with diminished ovarian reserve undergoing IVF-ICSI cycles	41
Health related quality of life and psychological parameters in different polycystic ovary syndrome phenotypes: a comparative cross-sectional study	41
Clinical application of PARP inhibitors in ovarian cancer: from molecular mechanisms to the current status	40
Clinical characteristics and risk factors of ovarian reserve decreases in women with Crohn’s disease: a case-control study	38
A novel heterozygous missense variant of PANX1 causes human oocyte death and female infertility	37
Proteomic analysis implicates that postovulatory aging leads to aberrant gene expression, biosynthesis, RNA metabolism and cell cycle in mouse oocytes	37
Trends in incidence and mortality for ovarian cancer in China from 1990 to 2019 and its forecasted levels in 30 years	37
Alterations in gonadotropin, apoptotic and metabolic pathways in granulosa cells warrant superior fertility of the Dummerstorf high fertility mouse line 1	36
Exploring the association of ESR1 and ESR2 gene SNPs with polycystic ovary syndrome in human females: a comprehensive association study	36
Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer	33
Maternal and perinatal risks for monozygotic twins conceived following frozen-thawed embryo transfer: a retrospective cohort study	33
Evaluation of calcification distribution by CT-based textural analysis for discrimination of immature teratoma	31
Controlled ovarian stimulation in cancer patients under 18 years old; a case series	31
Evaluation of the relationship between ovarian reserve with congenital anomalies and intramural uterine leiomyoma among infertile women: a cross-sectional study	30
Depletion of placental brain-derived neurotrophic factor (BDNF) is attributed to premature ovarian insufficiency (POI) in mice offspring	30
High expression level of miR-1260 family in the peripheral blood of patients with ovarian carcinoma	27
Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling	27
A real-world study of treatment patterns following disease progression in epithelial ovarian cancer patients undergoing poly-ADP-ribose polymerase inhibitor maintenance therapy	26
The possible short-term of Nigella sativa – L in the management of adolescent polycystic ovarian syndrome: results of a randomized controlled trial	24
Risk-reducing salpingo-oophorectomy among Chinese women at increased risk of breast and ovarian cancer	24

Mutations in CCNB3 affect its location thus causing a multiplicity of phenotypes in human oocytes maturation by aberrant CDK1 activity and APC/C activity at different stages	23
Identification of upregulated exosomal miRNAs between A2780 and A2780/DDP human ovarian cancer cells by high-throughput sequencing	22
Multi-omics reveal the metabolic patterns in mouse cumulus cells during oocyte maturation	22
Circular RNA circ-BNC2 (hsa_circ_0008732) inhibits the progression of ovarian cancer through microRNA-223-3p/ FBXW7 axis	22
The prolactin receptor gene (PRLR) is linked and associated with the risk of polycystic ovarian syndrome	20
Exploring the causal role of multiple metabolites on ovarian cancer: a two sample Mendelian randomization study	20
The melatonin receptor genes are linked and associated with the risk of polycystic ovary syndrome	20
The impact of oral isotretinoin on ovarian functions of acne patients complaining of polycystic ovarian syndrome: a prospective study	19
Epitranscriptome marks detection and localization of RNA modifying proteins in mammalian ovarian follicles	19
ErZhiTianGui Decoction alleviates age-related ovarian aging by regulating mitochondrial homeostasis and inhibiting ferroptosis	19
Can circulating cell free DNA be a promising marker in ovarian cancer? – a genome-scale profiling study in a single institution	19
Adding L-carnitine to antagonist ovarian stimulation doesn’t improve the outcomes of IVF/ ICSI cycle in patients with polycystic ovarian syndrome: a double-blind randomized clinical trial	19
Pretreatment with a long-acting GnRH agonist for frozen-thawed embryo transfer cycles: how to improve live birth?	18
The role of vitamin D3 in follicle development	18
Do ethnic chinese older adults with epithelial ovarian cancer survive a poorer prognosis?	18
Immune profile of primary and recurrent epithelial ovarian cancer cases indicates immune suppression, a major cause of progression and relapse of ovarian cancer	18
Biological and prognostic value of ETV5 in high-grade serous ovarian cancer	18
Can expelled cells/debris from a developing embryo be used for PGT?	17
Ovarian absence: a systematic literature review and case series report	17
Hexokinase 2 promoted cell motility and proliferation by activating Akt1/p-Akt1 in human ovarian cancer cells	17
Factors affecting cumulative live birth rate after the 1st oocyte retrieved in polycystic ovary syndrome patients in women during IVF/ICSI-ET	17
Evaluation of mitochondria in mouse oocytes following cisplatin exposure	17
Melatonin increases superoxide dismutase 2 (SOD2) levels and improves rat ovarian graft function after transplantation	17
Risk-stratified CA125 screening integrating CA125 trajectories, trajectory-specific progression and transvaginal ultrasound for ovarian cancer	17
Fertility-sparing surgery in children and adolescents with borderline ovarian tumors: a retrospective study	17
The efficacy and safety of angiogenesis inhibitors for recurrent ovarian cancer: a meta‑analysis	17
Anastomotic leakage after resection of the rectosigmoid colon in primary ovarian cancer	16
Long noncoding RNA SNHG25 promotes the malignancy of endometrial cancer by sponging microRNA-497-5p and increasing FASN expression	16
Luteinizing hormone stimulates the expression of amphiregulin in human theca cells	15
Evolutionary perspectives, heterogeneity and ovarian cancer: a complicated tale from past to present	15
Development and clinical validation of a seven-gene signature based on tumor stem cell-related genes to predict ovarian cancer prognosis	15
Novel variants in TUBB8 gene cause multiple phenotypic abnormalities in human oocytes and early embryos	15
Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet	15
Knowledge and attitudes towards clinical trials among women with ovarian cancer: results of the ACTO study	15
Single-cell RNA sequencing of human oocytes reveals a differential transcriptomic profile associated with agar-like zona pellucida	15
Expression of long noncoding RNAs in the ovarian granulosa cells of women with diminished ovarian reserve using high-throughput sequencing	15
Uterine involvement in epithelial ovarian cancer and its risk factors	15
Exploration and prognostic analysis of two types of high-risk ovarian cancers: clear cell vs. serous carcinoma: a population-based study	15
Two-dimensional and three-dimensional T2 weighted imaging-based radiomic signatures for the preoperative discrimination of ovarian borderline tumors and malignant tumors	14
Bevacizumab confers significant improvements in survival for ovarian cancer patients with low miR-25 expression and high miR-142 expression	14
Serum and follicular fluid levels of soluble receptor for advanced glycation end-products in women with and without polycystic ovary syndrome	14
Differences between primary peritoneal serous carcinoma and advanced serous ovarian carcinoma: a study based on the SEER database	14
Next-generation sequencing of 500 POI patients identified novel responsible monogenic and oligogenic variants	14
Meta-analysis of trigger timing in normal responders undergoing GnRH antagonist ovarian hyperstimulation protocol	14
CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer	14
MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer	13
Ovarian sex cord stromal tumours: analysis of the clinical and sonographic characteristics of different histopathologic subtypes	13
B4GALT5 a sialylation-related genes associated with patient prognosis and immune microenvironment in ovarian cancer and pan-cancer	13
Efficacy and safety of Shen Que (RN8) moxibustion on reproductive outcomes in unexpected poor ovarian responders: a randomized controlled trial	13
Cardiovascular mortality risk in patients with ovarian cancer: a population-based study	13

The diagnostic performance of CA-125 for the detection of ovarian cancer in women from different ethnic groups: a cohort study of English primary care data	13
Amplifications of EVX2 and HOXD9-HOXD13 on 2q31 in mature cystic teratomas of the ovary identified by array comparative genomic hybridization may explain teratoma characteristics in chondrogenesis and	12
Ovarian tissue cryopreservation in a patient with breast cancer during pregnancy: a case report	12
Exosomes in diagnostic and therapeutic applications of ovarian cancer	12
HOXB2 promotes cisplatin resistance by upregulating lncRNA DANCR in ovarian cancer	12
Prognostic significance and risk factors for pelvic and para-aortic lymph node metastasis in type I and type II ovarian cancer: a large population-based database analysis	12
Differences between complex epithelial neoplasms of the ovary and high-grade serous ovarian cancer: a retrospective observational cohort study	12
An EMT-based gene signature enhances the clinical understanding and prognostic prediction of patients with ovarian cancers	12
Causal association between low vitamin D and polycystic ovary syndrome: a bidirectional mendelian randomization study	12
The serum oestradiol/progesterone ratio on the day of OPU + 7, but not the day of OPU + 5, affects the rates of live birth in fresh blastocyst embryo transfer cycles	12
Protective effect of Luffa cylindrica fermentation liquid on cyclophosphamide-induced premature ovarian failure in female mice by attenuating oxidative stress, inflammation and apoptosis	12
External validation of Standardized KELIM and platinum-resistant recurrence scores in patients with advanced epithelial ovarian cancer	11
Maintenance therapy for newly diagnosed epithelial ovarian cancer– a review	11
PARP inhibitor era in ovarian cancer treatment: a systematic review and meta-analysis of randomized controlled trials	11
miR-362-3p acts as a tumor suppressor by targeting SERBP1 in ovarian cancer	11
Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers	11
Causal relationship between inflammatory cytokines and polycystic ovary syndrome: a bidirectional mendelian randomization study	11
LH level on ovulation trigger day has a different impact on the outcomes of agonist and antagonist regimens during in vitro fertilization	11
The enhancer RNA ADCY10P1 is associated with the progression of ovarian cancer	11
Long non-coding RNA OIP5-AS1 suppresses microRNA-92a to augment proliferation and metastasis of ovarian cancer cells through upregulating ITGA6	11
LncRNA RBAT1 reduces chemosensitivity of cancer cells to carboplatin/paclitaxel by sponging miR‑27b in endometrial carcinoma	11
KAS-seq profiling captures transcription dynamics during oocyte maturation	11
COVID-19 in Africa: an ovarian victory?	11
A preliminary study on the effects of Xiang Shao granules on reproductive endocrinology in drugged ovariectomised rats	11
BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy	11
Mitigation of letrozole induced polycystic ovarian syndrome associated inflammatory response and endocrinal dysfunction by Vitex negundo seeds	11
Cut-off point of mature oocyte for routine clinical application of rescue IVM: a retrospective cohort study	11
Molecular response to PARP1 inhibition in ovarian cancer cells as determined by mass spectrometry based proteomics	11
Effects of vitrified cryopreservation duration on IVF and neonatal outcomes	11
Effects of n-3 PUFA supplementation on oocyte in vitro maturation in mice with polycystic ovary syndrome	11
In-vivo oogenesis of oogonial and mesenchymal stem cells seeded in transplanted ovarian extracellular matrix	10
Comparison of oocyte vitrification using a semi-automated or a manual closed system in human siblings: survival and transcriptomic analyses	10
Correction: Metformin modifies plasma microbial-derived extracellular vesicles in polycystic ovary syndrome with insulin resistance	10
Trophectoderm biopsy of blastocysts for a preimplantation genetic test does not affect serum β-hCG levels in early pregnancy: a study using propensity score matching	10
Association between cytokines and progression-free survival in ovarian cancer following CRS/HIPEC treatment	10
Ovarian inguinal hernia – a possibility in MURCS syndrome	10
The role of oxidative stress in ovarian aging: a review	10
Ginseng alleviates folliculogenesis disorders via induction of cell proliferation and downregulation of apoptotic markers in nicotine-treated mice	10
Yu Linzhu alleviates primary ovarian insufficiency in a rat model by improving proliferation and energy metabolism of granulosa cells through hif1α/cx43 pathway	10
Correction: Alteration of the N6‑methyladenosine methylation landscape in a mouse model of polycystic ovary syndrome	10
Baicalein improves the chemoresistance of ovarian cancer through regulation of CirSLC7A6	10
The presence of ovarian endometrioma adversely affect ovarian reserve and response to stimulation but not oocyte quality or IVF/ICSI outcomes: a retrospective cohort study	10
CircCDK17 knockdown inhibits tumor progression and cell glycolysis by downregulaing YWHAZ expression through sponging miR-1294 in cervical cancer	10
Genetic determination of the ovarian reserve: a literature review	10
LncRNA DLEU1 is overexpressed in premature ovarian failure and sponges miR-146b-5p to increase granulosa cell apoptosis	10
Targeted proteomics of plasma extracellular vesicles uncovers MUC1 as combinatorial biomarker for the early detection of high-grade serous ovarian cancer	10
Correction: TP63 truncating mutation causes increased cell apoptosis and premature ovarian insufficiency by enhanced transcriptional activation of CLCA2	10
Molecular mechanism of Wilms’ tumor (Wt1) (+/−KTS) variants promoting proliferation and migration of ovarian epithelial cells by bioinformatics analysis	10
Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer	10
The synergistic mechanisms of propofol with cisplatin or doxorubicin in human ovarian cancer cells	10
Aged mice ovaries harbor stem cells and germ cell nests but fail to form follicles	9
Correction: Bone marrow mesenchymal stem cells expressing Neat-1, Hotair-1, miR-21, miR-644, and miR-144 subsided cyclophosphamide-induced ovarian insufficiency by remodeling the IGF-1–kisspeptin syst	9
Efficacy of three COS protocols and predictability of AMH and AFC in women with discordant ovarian reserve markers: a retrospective study on 19,239 patients	9
An unusual association of type II Mayer-Rokitansky-Kuster-Hauser syndrome, turner mosaic syndrome and tubo-ovarian inguinal hernia– case report and review of literature	9
Retraction Note: H3K27ac-induced lncRNA PAXIP1-AS1 promotes cell proliferation, migration, EMT and apoptosis in ovarian cancer by targeting miR-6744-5p/PCBP2 axis	9
The effect of calorie-restriction along with thylakoid membranes of spinach on the gut-brain Axis Pathway and oxidative stress biomarkers in obese women with polycystic ovary syndrome: a Randomized, D	9
Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma	9
Differences of survival benefits brought by various treatments in ovarian cancer patients with different tumor stages	9
Knockdown of heat shock protein family D member 1 (HSPD1) promotes proliferation and migration of ovarian cancer cells via disrupting the stability of mitochondrial 3-oxoacyl-ACP synthase (OXSM)	9
Stem cell-based therapeutic potential in female ovarian aging and infertility	9
Correction: In vitro drug testing using patient-derived ovarian cancer organoids	9
Interaction of lncRNA Gm2044 and EEF2 promotes estradiol synthesis in ovarian follicular granulosa cells	9
Subtype-specific analysis of gene co-expression networks and immune cell profiling reveals high grade serous ovarian cancer subtype linkage to variable immune microenvironment	9
Increased expression of KPNA2 predicts unfavorable prognosis in ovarian cancer patients, possibly by targeting KIF4A signaling	9
Placental mesenchymal stem cells ameliorate NLRP3 inflammasome-induced ovarian insufficiency by modulating macrophage M2 polarization	9
Changes in peripheral lymphocyte populations in patients with advanced/recurrent ovarian cancer undergoing splenectomy during cytoreductive surgery	9
No evidence for a diminished ovarian reserve among patients with hypertensive disorders of pregnancy: a case control study	9
Activation of PI3K/AKT/mTOR signaling axis by UBE2S inhibits autophagy leading to cisplatin resistance in ovarian cancer	9
Prognostic analysis of peritoneal washing cytology during interval debulking surgery in advanced ovarian cancer	9
Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo	9
An integrated machine learning-based model for joint diagnosis of ovarian cancer with multiple test indicators	9
Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus	9
Correction: H3K27ac-induced lncRNA PAXIP1-AS1 promotes cell proliferation, migration, EMT and apoptosis in ovarian cancer by targeting miR-6744-5p/PCBP2 axis	9
Retrospective analysis of GnRH-a prolonged protocol for in vitro fertilization in 18,272 cycles in China	9
Structural organization of the neuronal pathways of the superior ovarian nerve in the rat	9
The stromal microenvironment and ovarian aging: mechanisms and therapeutic opportunities	9
Successful live birth in a Chinese woman with P450 oxidoreductase deficiency through frozen-thawed embryo transfer: a case report with review of the literature	9
Pre-operative plasma VEGF-C levels portend recurrence in epithelial ovarian cancer patients and is a bankable prognostic marker even in the initial assessment of a patient	9
ERCC1 rs11615 polymorphism and chemosensitivity to platinum drugs in patients with ovarian cancer: a systematic review and meta-analysis	9
Retraction Note: Long non-coding RNA PTPRG-AS1 promotes cell tumorigenicity in epithelial ovarian cancer by decoying microRNA-545-3p and consequently enhancing HDAC4 expression	9

Personalization of IVF-ICSI workflow based on patient characteristics improves IVF laboratory outcomes and embryo ploidy by PGT-A	8
Near-infrared fluorescent molecular probes with cetuximab in the in vivo fluorescence imaging for epithelial ovarian cancer	8
Effects of electroacupuncture on the kisspeptin-gonadotropin-releasing hormone (GnRH) /luteinizing hormone (LH) neural circuit abnormalities and androgen receptor expression of kisspeptin/neurokinin B	8
Mechanisms of He Shi Yu Lin formula in treating premature ovarian insufficiency: insights from network pharmacology and animal experiments	8
Abnormalities of early folliculogenesis and serum anti-Müllerian hormone in chinese patients with polycystic ovary syndrome	8
Examining the oleoylethanolamide supplement effects on glycemic status, oxidative stress, inflammation, and anti-mullerian hormone in polycystic ovary syndrome	8
CACNA1C is a prognostic predictor for patients with ovarian cancer	8
Progestin and adipoQ receptor 7 (PAQR7) mediate the anti-apoptotic effect of P4 on human granulosa cells and its deficiency reduces ovarian function in female mice	8
Fisetin-induced cell death in human ovarian cancer cell lines via zbp1-mediated necroptosis	8
A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis	8
Knockdown of circ-FURIN suppresses the proliferation and induces apoptosis of granular cells in polycystic ovary syndrome via miR-195-5p/BCL2 axis	8
Investigation of androgen receptor CAG repeats length in polycystic ovary syndrome diagnosed using the new international evidence-based guideline	8
The impact of blastomere loss on pregnancy and neonatal outcomes of vitrified-warmed Day3 embryos in single embryo transfer cycles	8
Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors	8
Toxic effect window of ovarian development in female offspring mice induced by prenatal prednisone exposure with different doses and time	8
Combined analysis of estradiol and β-hCG to predict the early pregnancy outcome of FET: a retrospective study	8
Analysis of prognostic value of lactate metabolism-related genes in ovarian cancer based on bioinformatics	8
Ovarian fibrosis: molecular mechanisms and potential therapeutic targets	8
High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer	8
The experıance of tertıary center for adult granulosa cell tumor: whıch factors predıct survival?	8
LncRNA TMPO-AS1 suppresses the maturation of miR-335-5p to participate in polycystic ovary syndrome	8
Aneuploid serves as a prognostic marker and favors immunosuppressive microenvironment in ovarian cancer	8
MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells	8
Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer	8
Identification and validation of a gene-based signature reveals SLC25A10 as a novel prognostic indicator for patients with ovarian cancer	8
Molecular and biological functions of gingerol as a natural effective therapeutic drug for cervical cancer	8
Effect of melatonin supplementation on cardiometabolic risk factors, oxidative stress and hormonal profile in PCOS patients: a systematic review and meta-analysis of randomized clinical trials	8
A mouse model of neoadjuvant chemotherapy followed by interval cytoreductive surgery indicates impaired efficacy of perioperative cisplatin	8
Management of advanced ovarian cancer in Spain: an expert Delphi consensus	8
Knockdown of ENTPD5 inhibits tumor metastasis and growth via regulating the GRP78/p-eIF-2α/CHOP pathway in serous ovarian cancer	8
Differentially expression and function of circular RNAs in ovarian cancer stem cells	8
Metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with Germline BRCA1 mutation: a case report	8
BDNF promotes mouse follicular development and reverses ovarian aging by promoting cell proliferation	7
MiR-134-3p targets HMOX1 to inhibit ferroptosis in granulosa cells of sheep follicles	7
Dose inhibin B or anti-Müllerian hormone relate to precocious puberty in girls? result of a systematic review and meta-analysis	7
MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A	7
Lifetime ovulatory years and ovarian cancer gene expression profiles	7
The impact of Paclitaxel-based hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer patients - interim analysis of safety and immediate efficacy of a randomized contr	7
UBE2T regulates epithelial–mesenchymal transition through the PI3K-AKT pathway and plays a carcinogenic role in ovarian cancer	7
Diagnostic utility of a conventional MRI-based analysis and texture analysis for discriminating between ovarian thecoma-fibroma groups and ovarian granulosa cell tumors	7
The effect of paclitaxel- and fisetin-loaded PBM nanoparticles on apoptosis and reversal of drug resistance gene ABCG2 in ovarian cancer	7
Observation of the therapeutic effect of apatinib in advanced platinum-resistant recurrent epithelial ovarian cancer	7
Prognostic marker C3AR1 is associated with ovarian cancer cell proliferation and immunosuppression in the tumor microenvironment	7
Hsa_circ_0043532 contributes to PCOS through upregulation of CYP19A1 by acting as a ceRNA for hsa-miR-1270	7
Management of Borderline ovarian tumors (BOT): results of a retrospective, single center study in Switzerland	7
Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer	7
Cocultured porcine granulosa cells respond to excess non-esterified fatty acids during in vitro maturation	7
Characteristics and outcomes analysis of ovarian Sertoli–Leydig cell tumors (SLCTs): analysis of 15 patients	7
A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer	7
Comprehensive in silico analysis of prognostic and immune infiltrates for FGFs in human ovarian cancer	7
A novel defined programmed cell death related gene signature for predicting the prognosis of serous ovarian cancer	7
Sestrin1, 2, and 3 are dispensable for female fertility in mice	7
The long non-coding RNA NEAT1 promotes the progression of human ovarian cancer through targeting miR-214-3p and regulating angiogenesis	7
The glucocorticoid receptor gene (NR3C1) is linked to and associated with polycystic ovarian syndrome in Italian families	7
Low risk of OHSS with follitropin delta use in women with different polycystic ovary syndrome phenotypes: a retrospective case series	7
The ameliorative effect of selenium-loaded chitosan nanoparticles against silver nanoparticles-induced ovarian toxicity in female albino rats	7
From clinical management to personalized medicine: novel therapeutic approaches for ovarian clear cell cancer	7
LncRNA SNHG20 promotes migration and invasion of ovarian cancer via modulating the microRNA-148a/ROCK1 axis	7
Pro-cancerogenic effects of spontaneous and drug-induced senescence of ovarian cancer cells in vitro and in vivo: a comparative analysis	7
In vitro matured oocytes have a higher developmental potential than in vivo matured oocytes after hormonal ovarian stimulation in Callithrix jacchus	7
ADC: a deadly killer of platinum resistant ovarian cancer	6
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unveils heterogeneity and establishes a novel signature for prognosis and tumor immune microenvironment in ovarian cancer	6
Do we overlook predictive factors in Poseidon 1 patients? A retrospective analysis co-evaluating antral follicle counts & diameters	6
Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging	6
LCK facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancer	6
The PAPSS1 gene is a modulator of response to cisplatin by regulating estrogen receptor alpha signaling activity in ovarian cancer cells	6
Preparation of triangular silver nanoparticles and their biological effects in the treatment of ovarian cancer	6
Comparative efficacy and safety of metformin, anti-obesity agents, and myoinositol in improving IVF/ICSI outcomes and reducing ovarian hyperstimulation syndrome in women with polycystic ovary syndrome	6
Circular RNA hsa_circ_0000144 aggravates ovarian Cancer progression by regulating ELK3 via sponging miR-610	6
Protective effect of afamin protein against oxidative stress related injury in human ovarian granulosa cells	6
The effect of adipose-derived mesenchymal stem cell transplantation on ovarian mitochondrial dysfunction in letrozole-induced polycystic ovary syndrome in rats: the role of PI3K-AKT signaling pathway	6
A novel autophagy-related gene signature associated with prognosis and immune microenvironment in ovarian cancer	6
Folliculogenesis and steroidogenesis alterations after chronic exposure to a human-relevant mixture of environmental toxicants spare the ovarian reserve in the rabbit model	6
Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses	6
Dehydroepiandrosterone-induced polycystic ovary syndrome mouse model requires continous treatments to maintain reproductive phenotypes	6
Plasma circRNA microarray profiling identifies novel circRNA biomarkers for the diagnosis of ovarian cancer	6
Proteomic analysis of exosomes secreted during the epithelial-mesenchymal transition and potential biomarkers of mesenchymal high-grade serous ovarian carcinoma	6
Short (seven days) versus standard (fourteen days) oestrogen administration in a programmed frozen embryo transfer cycle: a retrospective cohort study	6
Effect of 150 kHz electromagnetic radiation on the development of polycystic ovaries induced by estradiol Valerate in Sprague Dawley rats	6
Premature ovarian insufficiency: a review on the role of tobacco smoke, its clinical harm, and treatment	6
Integration of single-cell RNA-seq and bulk RNA-seq data to construct and validate a cancer-associated fibroblast-related prognostic signature for patients with ovarian cancer	6
Circ_0078607 inhibits the progression of ovarian cancer via regulating the miR-32-5p/SIK1 network	6
Sialyl-Tn serves as a potential therapeutic target for ovarian cancer	6
Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients	6
Retraction Note: The significance of the change pattern of serum CA125 level for judging prognosis and diagnosing recurrences of epithelial ovarian cancer	5
In vitro drug testing using patient-derived ovarian cancer organoids	5
Bone marrow mesenchymal stem cells expressing Neat-1, Hotair-1, miR-21, miR-644, and miR-144 subsided cyclophosphamide-induced ovarian insufficiency by remodeling the IGF-1–kisspeptin system, ovarian	5
Retraction Note: ANGPTL4 functions as an oncogene through regulation of the ETV5/CDH5/AKT/MMP9 axis to promote angiogenesis in ovarian cancer	5
Correction to: ovarian stem cells are always accompanied by very small embryonic-like stem cells in adult mammalian ovary	5
Correlation between ovarian follicular development and Hippo pathway in polycystic ovary syndrome	5
Maelstrom promotes tumor metastasis through regulation of FGFR4 and epithelial-mesenchymal transition in epithelial ovarian cancer	5
Retraction Note: LncRNA miR503HG interacts with miR-31-5p through multiple ways to regulate cancer cell invasion and migration in ovarian cancer	5
Correction: Polycystic ovary rat model exposure to 150 kHz intermediate frequency: hypothalamic-pituitary-ovarian axis at the receptor, cellular, tissue, and hormone levels	5
Reverse-engineering the FLT3-PI3K/AKT axis to enhance TILs function and improve prognosis in ovarian and cervical cancers	5
Retraction Note: The role of apatinib combined with paclitaxel (aluminum binding type) in platinum-resistant ovarian cancer	5